Global Human Organs-on-Chips Model Market Growth 2026-2032

August 2026 | 144 pages | ID: GC9DC09798B8EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Human Organs-on-Chips Model market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

We have developed a range of validated Organ-Chip models that enable researchers to more closely emulate human biology by combining human cell sourcing, an organ-specific microenvironment, and tissue-relevant mechanical forces.

United States market for Human Organs-on-Chips Model is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Human Organs-on-Chips Model is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Human Organs-on-Chips Model is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Human Organs-on-Chips Model players cover Emulate, Mimetas, Cherry Biotech, CN Bio Innovations, Nortis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the “Human Organs-on-Chips Model Industry Forecast” looks at past sales and reviews total world Human Organs-on-Chips Model sales in 2025, providing a comprehensive analysis by region and market sector of projected Human Organs-on-Chips Model sales for 2026 through 2032. With Human Organs-on-Chips Model sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Organs-on-Chips Model industry.

This Insight Report provides a comprehensive analysis of the global Human Organs-on-Chips Model landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human Organs-on-Chips Model portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human Organs-on-Chips Model market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Organs-on-Chips Model and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Organs-on-Chips Model.

This report presents a comprehensive overview, market shares, and growth opportunities of Human Organs-on-Chips Model market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • Multi Organ Model
  • Single Organ Model
  • Human Tissue Model
Segmentation by Application:
  • Drug Development
  • Disease Modeling
  • Personalized Medicine
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Emulate
  • Mimetas
  • Cherry Biotech
  • CN Bio Innovations
  • Nortis
  • TissUse
  • BiomimX
  • Altis Biosystems
  • Ananda Devices
  • Netri
  • React4life
  • SynVivo
  • Draper Laboratory
  • AlveoliX
  • TNO
  • Hesperos
  • Abance Biotechnology
  • Beijing Daxiang Biotech
Key Questions Addressed in this Report
  • What is the 10-year outlook for the global Human Organs-on-Chips Model market?
  • What factors are driving Human Organs-on-Chips Model market growth, globally and by region?
  • Which technologies are poised for the fastest growth by market and region?
  • How do Human Organs-on-Chips Model market opportunities vary by end market size?
  • How does Human Organs-on-Chips Model break out by Type, by Application?
1 SCOPE OF THE REPORT

  1.1 Market Introduction
  1.2 Years Considered
  1.3 Research Objectives
  1.4 Market Research Methodology
  1.5 Research Process and Data Source
  1.6 Economic Indicators
  1.7 Currency Considered
  1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

  2.1 World Market Overview
  2.1.1 Global Human Organs-on-Chips Model Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Human Organs-on-Chips Model by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Human Organs-on-Chips Model by Country/Region, 2021, 2025 & 2032
  2.2 Human Organs-on-Chips Model Segment by Type
  2.2.1 Multi Organ Model
  2.2.2 Single Organ Model
  2.2.3 Human Tissue Model
  2.2.4 Human Organs-on-Chips Model Sales by Type
  2.2.4.1 Global Human Organs-on-Chips Model Sales Market Share by Type (2021-2026)
  2.2.4.2 Global Human Organs-on-Chips Model Revenue and Market Share by Type (2021-2026)
  2.2.4.3 Global Human Organs-on-Chips Model Sale Price by Type (2021-2026)
  2.3 Human Organs-on-Chips Model Segment by Application
  2.3.1 Drug Development
  2.3.2 Disease Modeling
  2.3.3 Personalized Medicine
  2.3.4 Others
  2.3.5 Human Organs-on-Chips Model Sales by Application
  2.3.5.1 Global Human Organs-on-Chips Model Sale Market Share by Application (2021-2026)
  2.3.5.2 Global Human Organs-on-Chips Model Revenue and Market Share by Application (2021-2026)
  2.3.5.3 Global Human Organs-on-Chips Model Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

  3.1 Global Human Organs-on-Chips Model Breakdown Data by Company
  3.1.1 Global Human Organs-on-Chips Model Annual Sales by Company (2021-2026)
  3.1.2 Global Human Organs-on-Chips Model Sales Market Share by Company (2021-2026)
  3.2 Global Human Organs-on-Chips Model Annual Revenue by Company (2021-2026)
  3.2.1 Global Human Organs-on-Chips Model Revenue by Company (2021-2026)
  3.2.2 Global Human Organs-on-Chips Model Revenue Market Share by Company (2021-2026)
  3.3 Global Human Organs-on-Chips Model Sale Price by Company
  3.4 Key Manufacturers Human Organs-on-Chips Model Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Human Organs-on-Chips Model Product Location Distribution
  3.4.2 Players Human Organs-on-Chips Model Products Offered
  3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
  3.6 New Products and Potential Entrants
  3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR HUMAN ORGANS-ON-CHIPS MODEL BY GEOGRAPHIC REGION

  4.1 World Historic Human Organs-on-Chips Model Market Size by Geographic Region (2021-2026)
  4.1.1 Global Human Organs-on-Chips Model Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Human Organs-on-Chips Model Annual Revenue by Geographic Region (2021-2026)
  4.2 World Historic Human Organs-on-Chips Model Market Size by Country/Region (2021-2026)
  4.2.1 Global Human Organs-on-Chips Model Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Human Organs-on-Chips Model Annual Revenue by Country/Region (2021-2026)
  4.3 Americas Human Organs-on-Chips Model Sales Growth
  4.4 APAC Human Organs-on-Chips Model Sales Growth
  4.5 Europe Human Organs-on-Chips Model Sales Growth
  4.6 Middle East & Africa Human Organs-on-Chips Model Sales Growth

5 AMERICAS

  5.1 Americas Human Organs-on-Chips Model Sales by Country
  5.1.1 Americas Human Organs-on-Chips Model Sales by Country (2021-2026)
  5.1.2 Americas Human Organs-on-Chips Model Revenue by Country (2021-2026)
  5.2 Americas Human Organs-on-Chips Model Sales by Type (2021-2026)
  5.3 Americas Human Organs-on-Chips Model Sales by Application (2021-2026)
  5.4 United States
  5.5 Canada
  5.6 Mexico
  5.7 Brazil

6 APAC

  6.1 APAC Human Organs-on-Chips Model Sales by Region
  6.1.1 APAC Human Organs-on-Chips Model Sales by Region (2021-2026)
  6.1.2 APAC Human Organs-on-Chips Model Revenue by Region (2021-2026)
  6.2 APAC Human Organs-on-Chips Model Sales by Type (2021-2026)
  6.3 APAC Human Organs-on-Chips Model Sales by Application (2021-2026)
  6.4 China
  6.5 Japan
  6.6 South Korea
  6.7 Southeast Asia
  6.8 India
  6.9 Australia
  6.10 China Taiwan

7 EUROPE

  7.1 Europe Human Organs-on-Chips Model by Country
  7.1.1 Europe Human Organs-on-Chips Model Sales by Country (2021-2026)
  7.1.2 Europe Human Organs-on-Chips Model Revenue by Country (2021-2026)
  7.2 Europe Human Organs-on-Chips Model Sales by Type (2021-2026)
  7.3 Europe Human Organs-on-Chips Model Sales by Application (2021-2026)
  7.4 Germany
  7.5 France
  7.6 UK
  7.7 Italy
  7.8 Russia

8 MIDDLE EAST & AFRICA

  8.1 Middle East & Africa Human Organs-on-Chips Model by Country
  8.1.1 Middle East & Africa Human Organs-on-Chips Model Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Human Organs-on-Chips Model Revenue by Country (2021-2026)
  8.2 Middle East & Africa Human Organs-on-Chips Model Sales by Type (2021-2026)
  8.3 Middle East & Africa Human Organs-on-Chips Model Sales by Application (2021-2026)
  8.4 Egypt
  8.5 South Africa
  8.6 Israel
  8.7 Turkey
  8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

  9.1 Market Drivers & Growth Opportunities
  9.2 Market Challenges & Risks
  9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

  10.1 Raw Material and Suppliers
  10.2 Manufacturing Cost Structure Analysis of Human Organs-on-Chips Model
  10.3 Manufacturing Process Analysis of Human Organs-on-Chips Model
  10.4 Industry Chain Structure of Human Organs-on-Chips Model

11 MARKETING, DISTRIBUTORS AND CUSTOMER

  11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
  11.2 Human Organs-on-Chips Model Distributors
  11.3 Human Organs-on-Chips Model Customer

12 WORLD FORECAST REVIEW FOR HUMAN ORGANS-ON-CHIPS MODEL BY GEOGRAPHIC REGION

  12.1 Global Human Organs-on-Chips Model Market Size Forecast by Region
  12.1.1 Global Human Organs-on-Chips Model Forecast by Region (2027-2032)
  12.1.2 Global Human Organs-on-Chips Model Annual Revenue Forecast by Region (2027-2032)
  12.2 Americas Forecast by Country (2027-2032)
  12.3 APAC Forecast by Region (2027-2032)
  12.4 Europe Forecast by Country (2027-2032)
  12.5 Middle East & Africa Forecast by Country (2027-2032)
  12.6 Global Human Organs-on-Chips Model Forecast by Type (2027-2032)
  12.7 Global Human Organs-on-Chips Model Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

  13.1 Emulate
  13.1.1 Emulate Company Information
  13.1.2 Emulate Human Organs-on-Chips Model Product Portfolios and Specifications
  13.1.3 Emulate Human Organs-on-Chips Model Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Emulate Main Business Overview
  13.1.5 Emulate Latest Developments
  13.2 Mimetas
  13.2.1 Mimetas Company Information
  13.2.2 Mimetas Human Organs-on-Chips Model Product Portfolios and Specifications
  13.2.3 Mimetas Human Organs-on-Chips Model Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Mimetas Main Business Overview
  13.2.5 Mimetas Latest Developments
  13.3 Cherry Biotech
  13.3.1 Cherry Biotech Company Information
  13.3.2 Cherry Biotech Human Organs-on-Chips Model Product Portfolios and Specifications
  13.3.3 Cherry Biotech Human Organs-on-Chips Model Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Cherry Biotech Main Business Overview
  13.3.5 Cherry Biotech Latest Developments
  13.4 CN Bio Innovations
  13.4.1 CN Bio Innovations Company Information
  13.4.2 CN Bio Innovations Human Organs-on-Chips Model Product Portfolios and Specifications
  13.4.3 CN Bio Innovations Human Organs-on-Chips Model Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 CN Bio Innovations Main Business Overview
  13.4.5 CN Bio Innovations Latest Developments
  13.5 Nortis
  13.5.1 Nortis Company Information
  13.5.2 Nortis Human Organs-on-Chips Model Product Portfolios and Specifications
  13.5.3 Nortis Human Organs-on-Chips Model Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 Nortis Main Business Overview
  13.5.5 Nortis Latest Developments
  13.6 TissUse
  13.6.1 TissUse Company Information
  13.6.2 TissUse Human Organs-on-Chips Model Product Portfolios and Specifications
  13.6.3 TissUse Human Organs-on-Chips Model Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 TissUse Main Business Overview
  13.6.5 TissUse Latest Developments
  13.7 BiomimX
  13.7.1 BiomimX Company Information
  13.7.2 BiomimX Human Organs-on-Chips Model Product Portfolios and Specifications
  13.7.3 BiomimX Human Organs-on-Chips Model Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 BiomimX Main Business Overview
  13.7.5 BiomimX Latest Developments
  13.8 Altis Biosystems
  13.8.1 Altis Biosystems Company Information
  13.8.2 Altis Biosystems Human Organs-on-Chips Model Product Portfolios and Specifications
  13.8.3 Altis Biosystems Human Organs-on-Chips Model Sales, Revenue, Price and Gross Margin (2021-2026)
  13.8.4 Altis Biosystems Main Business Overview
  13.8.5 Altis Biosystems Latest Developments
  13.9 Ananda Devices
  13.9.1 Ananda Devices Company Information
  13.9.2 Ananda Devices Human Organs-on-Chips Model Product Portfolios and Specifications
  13.9.3 Ananda Devices Human Organs-on-Chips Model Sales, Revenue, Price and Gross Margin (2021-2026)
  13.9.4 Ananda Devices Main Business Overview
  13.9.5 Ananda Devices Latest Developments
  13.10 Netri
  13.10.1 Netri Company Information
  13.10.2 Netri Human Organs-on-Chips Model Product Portfolios and Specifications
  13.10.3 Netri Human Organs-on-Chips Model Sales, Revenue, Price and Gross Margin (2021-2026)
  13.10.4 Netri Main Business Overview
  13.10.5 Netri Latest Developments
  13.11 React4life
  13.11.1 React4life Company Information
  13.11.2 React4life Human Organs-on-Chips Model Product Portfolios and Specifications
  13.11.3 React4life Human Organs-on-Chips Model Sales, Revenue, Price and Gross Margin (2021-2026)
  13.11.4 React4life Main Business Overview
  13.11.5 React4life Latest Developments
  13.12 SynVivo
  13.12.1 SynVivo Company Information
  13.12.2 SynVivo Human Organs-on-Chips Model Product Portfolios and Specifications
  13.12.3 SynVivo Human Organs-on-Chips Model Sales, Revenue, Price and Gross Margin (2021-2026)
  13.12.4 SynVivo Main Business Overview
  13.12.5 SynVivo Latest Developments
  13.13 Draper Laboratory
  13.13.1 Draper Laboratory Company Information
  13.13.2 Draper Laboratory Human Organs-on-Chips Model Product Portfolios and Specifications
  13.13.3 Draper Laboratory Human Organs-on-Chips Model Sales, Revenue, Price and Gross Margin (2021-2026)
  13.13.4 Draper Laboratory Main Business Overview
  13.13.5 Draper Laboratory Latest Developments
  13.14 AlveoliX
  13.14.1 AlveoliX Company Information
  13.14.2 AlveoliX Human Organs-on-Chips Model Product Portfolios and Specifications
  13.14.3 AlveoliX Human Organs-on-Chips Model Sales, Revenue, Price and Gross Margin (2021-2026)
  13.14.4 AlveoliX Main Business Overview
  13.14.5 AlveoliX Latest Developments
  13.15 TNO
  13.15.1 TNO Company Information
  13.15.2 TNO Human Organs-on-Chips Model Product Portfolios and Specifications
  13.15.3 TNO Human Organs-on-Chips Model Sales, Revenue, Price and Gross Margin (2021-2026)
  13.15.4 TNO Main Business Overview
  13.15.5 TNO Latest Developments
  13.16 Hesperos
  13.16.1 Hesperos Company Information
  13.16.2 Hesperos Human Organs-on-Chips Model Product Portfolios and Specifications
  13.16.3 Hesperos Human Organs-on-Chips Model Sales, Revenue, Price and Gross Margin (2021-2026)
  13.16.4 Hesperos Main Business Overview
  13.16.5 Hesperos Latest Developments
  13.17 Abance Biotechnology
  13.17.1 Abance Biotechnology Company Information
  13.17.2 Abance Biotechnology Human Organs-on-Chips Model Product Portfolios and Specifications
  13.17.3 Abance Biotechnology Human Organs-on-Chips Model Sales, Revenue, Price and Gross Margin (2021-2026)
  13.17.4 Abance Biotechnology Main Business Overview
  13.17.5 Abance Biotechnology Latest Developments
  13.18 Beijing Daxiang Biotech
  13.18.1 Beijing Daxiang Biotech Company Information
  13.18.2 Beijing Daxiang Biotech Human Organs-on-Chips Model Product Portfolios and Specifications
  13.18.3 Beijing Daxiang Biotech Human Organs-on-Chips Model Sales, Revenue, Price and Gross Margin (2021-2026)
  13.18.4 Beijing Daxiang Biotech Main Business Overview
  13.18.5 Beijing Daxiang Biotech Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Human Organs-on-Chips Model Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Human Organs-on-Chips Model Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Multi Organ Model
Table 4. Major Players of Single Organ Model
Table 5. Major Players of Human Tissue Model
Table 6. Global Human Organs-on-Chips Model Sales by Type (2021-2026) & (Units)
Table 7. Global Human Organs-on-Chips Model Sales Market Share by Type (2021-2026)
Table 8. Global Human Organs-on-Chips Model Revenue by Type (2021-2026) & ($ million)
Table 9. Global Human Organs-on-Chips Model Revenue Market Share by Type (2021-2026)
Table 10. Global Human Organs-on-Chips Model Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Human Organs-on-Chips Model Sale by Application (2021-2026) & (Units)
Table 12. Global Human Organs-on-Chips Model Sale Market Share by Application (2021-2026)
Table 13. Global Human Organs-on-Chips Model Revenue by Application (2021-2026) & ($ million)
Table 14. Global Human Organs-on-Chips Model Revenue Market Share by Application (2021-2026)
Table 15. Global Human Organs-on-Chips Model Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Human Organs-on-Chips Model Sales by Company (2021-2026) & (Units)
Table 17. Global Human Organs-on-Chips Model Sales Market Share by Company (2021-2026)
Table 18. Global Human Organs-on-Chips Model Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Human Organs-on-Chips Model Revenue Market Share by Company (2021-2026)
Table 20. Global Human Organs-on-Chips Model Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Human Organs-on-Chips Model Producing Area Distribution and Sales Area
Table 22. Players Human Organs-on-Chips Model Products Offered
Table 23. Human Organs-on-Chips Model Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Human Organs-on-Chips Model Sales by Geographic Region (2021-2026) & (Units)
Table 27. Global Human Organs-on-Chips Model Sales Market Share Geographic Region (2021-2026)
Table 28. Global Human Organs-on-Chips Model Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Human Organs-on-Chips Model Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Human Organs-on-Chips Model Sales by Country/Region (2021-2026) & (Units)
Table 31. Global Human Organs-on-Chips Model Sales Market Share by Country/Region (2021-2026)
Table 32. Global Human Organs-on-Chips Model Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Human Organs-on-Chips Model Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Human Organs-on-Chips Model Sales by Country (2021-2026) & (Units)
Table 35. Americas Human Organs-on-Chips Model Sales Market Share by Country (2021-2026)
Table 36. Americas Human Organs-on-Chips Model Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Human Organs-on-Chips Model Sales by Type (2021-2026) & (Units)
Table 38. Americas Human Organs-on-Chips Model Sales by Application (2021-2026) & (Units)
Table 39. APAC Human Organs-on-Chips Model Sales by Region (2021-2026) & (Units)
Table 40. APAC Human Organs-on-Chips Model Sales Market Share by Region (2021-2026)
Table 41. APAC Human Organs-on-Chips Model Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Human Organs-on-Chips Model Sales by Type (2021-2026) & (Units)
Table 43. APAC Human Organs-on-Chips Model Sales by Application (2021-2026) & (Units)
Table 44. Europe Human Organs-on-Chips Model Sales by Country (2021-2026) & (Units)
Table 45. Europe Human Organs-on-Chips Model Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Human Organs-on-Chips Model Sales by Type (2021-2026) & (Units)
Table 47. Europe Human Organs-on-Chips Model Sales by Application (2021-2026) & (Units)
Table 48. Middle East & Africa Human Organs-on-Chips Model Sales by Country (2021-2026) & (Units)
Table 49. Middle East & Africa Human Organs-on-Chips Model Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Human Organs-on-Chips Model Sales by Type (2021-2026) & (Units)
Table 51. Middle East & Africa Human Organs-on-Chips Model Sales by Application (2021-2026) & (Units)
Table 52. Key Market Drivers & Growth Opportunities of Human Organs-on-Chips Model
Table 53. Key Market Challenges & Risks of Human Organs-on-Chips Model
Table 54. Key Industry Trends of Human Organs-on-Chips Model
Table 55. Human Organs-on-Chips Model Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Human Organs-on-Chips Model Distributors List
Table 58. Human Organs-on-Chips Model Customer List
Table 59. Global Human Organs-on-Chips Model Sales Forecast by Region (2027-2032) & (Units)
Table 60. Global Human Organs-on-Chips Model Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Human Organs-on-Chips Model Sales Forecast by Country (2027-2032) & (Units)
Table 62. Americas Human Organs-on-Chips Model Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Human Organs-on-Chips Model Sales Forecast by Region (2027-2032) & (Units)
Table 64. APAC Human Organs-on-Chips Model Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Human Organs-on-Chips Model Sales Forecast by Country (2027-2032) & (Units)
Table 66. Europe Human Organs-on-Chips Model Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Human Organs-on-Chips Model Sales Forecast by Country (2027-2032) & (Units)
Table 68. Middle East & Africa Human Organs-on-Chips Model Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Human Organs-on-Chips Model Sales Forecast by Type (2027-2032) & (Units)
Table 70. Global Human Organs-on-Chips Model Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Human Organs-on-Chips Model Sales Forecast by Application (2027-2032) & (Units)
Table 72. Global Human Organs-on-Chips Model Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Emulate Basic Information, Human Organs-on-Chips Model Manufacturing Base, Sales Area and Its Competitors
Table 74. Emulate Human Organs-on-Chips Model Product Portfolios and Specifications
Table 75. Emulate Human Organs-on-Chips Model Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Emulate Main Business
Table 77. Emulate Latest Developments
Table 78. Mimetas Basic Information, Human Organs-on-Chips Model Manufacturing Base, Sales Area and Its Competitors
Table 79. Mimetas Human Organs-on-Chips Model Product Portfolios and Specifications
Table 80. Mimetas Human Organs-on-Chips Model Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Mimetas Main Business
Table 82. Mimetas Latest Developments
Table 83. Cherry Biotech Basic Information, Human Organs-on-Chips Model Manufacturing Base, Sales Area and Its Competitors
Table 84. Cherry Biotech Human Organs-on-Chips Model Product Portfolios and Specifications
Table 85. Cherry Biotech Human Organs-on-Chips Model Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Cherry Biotech Main Business
Table 87. Cherry Biotech Latest Developments
Table 88. CN Bio Innovations Basic Information, Human Organs-on-Chips Model Manufacturing Base, Sales Area and Its Competitors
Table 89. CN Bio Innovations Human Organs-on-Chips Model Product Portfolios and Specifications
Table 90. CN Bio Innovations Human Organs-on-Chips Model Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. CN Bio Innovations Main Business
Table 92. CN Bio Innovations Latest Developments
Table 93. Nortis Basic Information, Human Organs-on-Chips Model Manufacturing Base, Sales Area and Its Competitors
Table 94. Nortis Human Organs-on-Chips Model Product Portfolios and Specifications
Table 95. Nortis Human Organs-on-Chips Model Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Nortis Main Business
Table 97. Nortis Latest Developments
Table 98. TissUse Basic Information, Human Organs-on-Chips Model Manufacturing Base, Sales Area and Its Competitors
Table 99. TissUse Human Organs-on-Chips Model Product Portfolios and Specifications
Table 100. TissUse Human Organs-on-Chips Model Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. TissUse Main Business
Table 102. TissUse Latest Developments
Table 103. BiomimX Basic Information, Human Organs-on-Chips Model Manufacturing Base, Sales Area and Its Competitors
Table 104. BiomimX Human Organs-on-Chips Model Product Portfolios and Specifications
Table 105. BiomimX Human Organs-on-Chips Model Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. BiomimX Main Business
Table 107. BiomimX Latest Developments
Table 108. Altis Biosystems Basic Information, Human Organs-on-Chips Model Manufacturing Base, Sales Area and Its Competitors
Table 109. Altis Biosystems Human Organs-on-Chips Model Product Portfolios and Specifications
Table 110. Altis Biosystems Human Organs-on-Chips Model Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Altis Biosystems Main Business
Table 112. Altis Biosystems Latest Developments
Table 113. Ananda Devices Basic Information, Human Organs-on-Chips Model Manufacturing Base, Sales Area and Its Competitors
Table 114. Ananda Devices Human Organs-on-Chips Model Product Portfolios and Specifications
Table 115. Ananda Devices Human Organs-on-Chips Model Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Ananda Devices Main Business
Table 117. Ananda Devices Latest Developments
Table 118. Netri Basic Information, Human Organs-on-Chips Model Manufacturing Base, Sales Area and Its Competitors
Table 119. Netri Human Organs-on-Chips Model Product Portfolios and Specifications
Table 120. Netri Human Organs-on-Chips Model Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Netri Main Business
Table 122. Netri Latest Developments
Table 123. React4life Basic Information, Human Organs-on-Chips Model Manufacturing Base, Sales Area and Its Competitors
Table 124. React4life Human Organs-on-Chips Model Product Portfolios and Specifications
Table 125. React4life Human Organs-on-Chips Model Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. React4life Main Business
Table 127. React4life Latest Developments
Table 128. SynVivo Basic Information, Human Organs-on-Chips Model Manufacturing Base, Sales Area and Its Competitors
Table 129. SynVivo Human Organs-on-Chips Model Product Portfolios and Specifications
Table 130. SynVivo Human Organs-on-Chips Model Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. SynVivo Main Business
Table 132. SynVivo Latest Developments
Table 133. Draper Laboratory Basic Information, Human Organs-on-Chips Model Manufacturing Base, Sales Area and Its Competitors
Table 134. Draper Laboratory Human Organs-on-Chips Model Product Portfolios and Specifications
Table 135. Draper Laboratory Human Organs-on-Chips Model Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. Draper Laboratory Main Business
Table 137. Draper Laboratory Latest Developments
Table 138. AlveoliX Basic Information, Human Organs-on-Chips Model Manufacturing Base, Sales Area and Its Competitors
Table 139. AlveoliX Human Organs-on-Chips Model Product Portfolios and Specifications
Table 140. AlveoliX Human Organs-on-Chips Model Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. AlveoliX Main Business
Table 142. AlveoliX Latest Developments
Table 143. TNO Basic Information, Human Organs-on-Chips Model Manufacturing Base, Sales Area and Its Competitors
Table 144. TNO Human Organs-on-Chips Model Product Portfolios and Specifications
Table 145. TNO Human Organs-on-Chips Model Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 146. TNO Main Business
Table 147. TNO Latest Developments
Table 148. Hesperos Basic Information, Human Organs-on-Chips Model Manufacturing Base, Sales Area and Its Competitors
Table 149. Hesperos Human Organs-on-Chips Model Product Portfolios and Specifications
Table 150. Hesperos Human Organs-on-Chips Model Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 151. Hesperos Main Business
Table 152. Hesperos Latest Developments
Table 153. Abance Biotechnology Basic Information, Human Organs-on-Chips Model Manufacturing Base, Sales Area and Its Competitors
Table 154. Abance Biotechnology Human Organs-on-Chips Model Product Portfolios and Specifications
Table 155. Abance Biotechnology Human Organs-on-Chips Model Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 156. Abance Biotechnology Main Business
Table 157. Abance Biotechnology Latest Developments
Table 158. Beijing Daxiang Biotech Basic Information, Human Organs-on-Chips Model Manufacturing Base, Sales Area and Its Competitors
Table 159. Beijing Daxiang Biotech Human Organs-on-Chips Model Product Portfolios and Specifications
Table 160. Beijing Daxiang Biotech Human Organs-on-Chips Model Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 161. Beijing Daxiang Biotech Main Business
Table 162. Beijing Daxiang Biotech Latest Developments

LIST OF FIGURES

Figure 1. Picture of Human Organs-on-Chips Model
Figure 2. Human Organs-on-Chips Model Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Organs-on-Chips Model Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Human Organs-on-Chips Model Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Human Organs-on-Chips Model Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Human Organs-on-Chips Model Sales Market Share by Country/Region (2025)
Figure 10. Human Organs-on-Chips Model Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Multi Organ Model
Figure 12. Product Picture of Single Organ Model
Figure 13. Product Picture of Human Tissue Model
Figure 14. Global Human Organs-on-Chips Model Sales Market Share by Type in 2026
Figure 15. Global Human Organs-on-Chips Model Revenue Market Share by Type (2021-2026)
Figure 16. Human Organs-on-Chips Model Consumed in Drug Development
Figure 17. Global Human Organs-on-Chips Model Market: Drug Development (2021-2026) & (Units)
Figure 18. Human Organs-on-Chips Model Consumed in Disease Modeling
Figure 19. Global Human Organs-on-Chips Model Market: Disease Modeling (2021-2026) & (Units)
Figure 20. Human Organs-on-Chips Model Consumed in Personalized Medicine
Figure 21. Global Human Organs-on-Chips Model Market: Personalized Medicine (2021-2026) & (Units)
Figure 22. Human Organs-on-Chips Model Consumed in Others
Figure 23. Global Human Organs-on-Chips Model Market: Others (2021-2026) & (Units)
Figure 24. Global Human Organs-on-Chips Model Sale Market Share by Application (2025)
Figure 25. Global Human Organs-on-Chips Model Revenue Market Share by Application in 2026
Figure 26. Human Organs-on-Chips Model Sales by Company in 2026 (Units)
Figure 27. Global Human Organs-on-Chips Model Sales Market Share by Company in 2026
Figure 28. Human Organs-on-Chips Model Revenue by Company in 2026 ($ millions)
Figure 29. Global Human Organs-on-Chips Model Revenue Market Share by Company in 2026
Figure 30. Global Human Organs-on-Chips Model Sales Market Share by Geographic Region (2021-2026)
Figure 31. Global Human Organs-on-Chips Model Revenue Market Share by Geographic Region in 2026
Figure 32. Americas Human Organs-on-Chips Model Sales 2021-2026 (Units)
Figure 33. Americas Human Organs-on-Chips Model Revenue 2021-2026 ($ millions)
Figure 34. APAC Human Organs-on-Chips Model Sales 2021-2026 (Units)
Figure 35. APAC Human Organs-on-Chips Model Revenue 2021-2026 ($ millions)
Figure 36. Europe Human Organs-on-Chips Model Sales 2021-2026 (Units)
Figure 37. Europe Human Organs-on-Chips Model Revenue 2021-2026 ($ millions)
Figure 38. Middle East & Africa Human Organs-on-Chips Model Sales 2021-2026 (Units)
Figure 39. Middle East & Africa Human Organs-on-Chips Model Revenue 2021-2026 ($ millions)
Figure 40. Americas Human Organs-on-Chips Model Sales Market Share by Country in 2026
Figure 41. Americas Human Organs-on-Chips Model Revenue Market Share by Country (2021-2026)
Figure 42. Americas Human Organs-on-Chips Model Sales Market Share by Type (2021-2026)
Figure 43. Americas Human Organs-on-Chips Model Sales Market Share by Application (2021-2026)
Figure 44. United States Human Organs-on-Chips Model Revenue Growth 2021-2026 ($ millions)
Figure 45. Canada Human Organs-on-Chips Model Revenue Growth 2021-2026 ($ millions)
Figure 46. Mexico Human Organs-on-Chips Model Revenue Growth 2021-2026 ($ millions)
Figure 47. Brazil Human Organs-on-Chips Model Revenue Growth 2021-2026 ($ millions)
Figure 48. APAC Human Organs-on-Chips Model Sales Market Share by Region in 2026
Figure 49. APAC Human Organs-on-Chips Model Revenue Market Share by Region (2021-2026)
Figure 50. APAC Human Organs-on-Chips Model Sales Market Share by Type (2021-2026)
Figure 51. APAC Human Organs-on-Chips Model Sales Market Share by Application (2021-2026)
Figure 52. China Human Organs-on-Chips Model Revenue Growth 2021-2026 ($ millions)
Figure 53. Japan Human Organs-on-Chips Model Revenue Growth 2021-2026 ($ millions)
Figure 54. South Korea Human Organs-on-Chips Model Revenue Growth 2021-2026 ($ millions)
Figure 55. Southeast Asia Human Organs-on-Chips Model Revenue Growth 2021-2026 ($ millions)
Figure 56. India Human Organs-on-Chips Model Revenue Growth 2021-2026 ($ millions)
Figure 57. Australia Human Organs-on-Chips Model Revenue Growth 2021-2026 ($ millions)
Figure 58. China Taiwan Human Organs-on-Chips Model Revenue Growth 2021-2026 ($ millions)
Figure 59. Europe Human Organs-on-Chips Model Sales Market Share by Country in 2026
Figure 60. Europe Human Organs-on-Chips Model Revenue Market Share by Country (2021-2026)
Figure 61. Europe Human Organs-on-Chips Model Sales Market Share by Type (2021-2026)
Figure 62. Europe Human Organs-on-Chips Model Sales Market Share by Application (2021-2026)
Figure 63. Germany Human Organs-on-Chips Model Revenue Growth 2021-2026 ($ millions)
Figure 64. France Human Organs-on-Chips Model Revenue Growth 2021-2026 ($ millions)
Figure 65. UK Human Organs-on-Chips Model Revenue Growth 2021-2026 ($ millions)
Figure 66. Italy Human Organs-on-Chips Model Revenue Growth 2021-2026 ($ millions)
Figure 67. Russia Human Organs-on-Chips Model Revenue Growth 2021-2026 ($ millions)
Figure 68. Middle East & Africa Human Organs-on-Chips Model Sales Market Share by Country (2021-2026)
Figure 69. Middle East & Africa Human Organs-on-Chips Model Sales Market Share by Type (2021-2026)
Figure 70. Middle East & Africa Human Organs-on-Chips Model Sales Market Share by Application (2021-2026)
Figure 71. Egypt Human Organs-on-Chips Model Revenue Growth 2021-2026 ($ millions)
Figure 72. South Africa Human Organs-on-Chips Model Revenue Growth 2021-2026 ($ millions)
Figure 73. Israel Human Organs-on-Chips Model Revenue Growth 2021-2026 ($ millions)
Figure 74. Turkey Human Organs-on-Chips Model Revenue Growth 2021-2026 ($ millions)
Figure 75. GCC Countries Human Organs-on-Chips Model Revenue Growth 2021-2026 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Human Organs-on-Chips Model in 2026
Figure 77. Manufacturing Process Analysis of Human Organs-on-Chips Model
Figure 78. Industry Chain Structure of Human Organs-on-Chips Model
Figure 79. Channels of Distribution
Figure 80. Global Human Organs-on-Chips Model Sales Market Forecast by Region (2027-2032)
Figure 81. Global Human Organs-on-Chips Model Revenue Market Share Forecast by Region (2027-2032)
Figure 82. Global Human Organs-on-Chips Model Sales Market Share Forecast by Type (2027-2032)
Figure 83. Global Human Organs-on-Chips Model Revenue Market Share Forecast by Type (2027-2032)
Figure 84. Global Human Organs-on-Chips Model Sales Market Share Forecast by Application (2027-2032)
Figure 85. Global Human Organs-on-Chips Model Revenue Market Share Forecast by Application (2027-2032)


More Publications